NASDAQ:PRQR
ProQR Therapeutics N.V. Stock News
$1.94
-0.0300 (-1.52%)
At Close: Apr 30, 2024
ProQR Announces Upcoming Investor Conferences
08:00am, Friday, 03'rd Sep 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tra
ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference
04:30pm, Wednesday, 11'th Aug 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tran
ProQR Announces Second Quarter 2021 Operating and Financial Results
07:00am, Thursday, 05'th Aug 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tr
ProQR Therapeutics: Looks Interesting Ahead Of Next Year's Pivotal Data
01:18pm, Sunday, 20'th Jun 2021
PRQR is using antisense RNA technology to target inherited retinal diseases. They have strong data from one indication, and decent data from another.
PRQR Stock: From $6.36 To $6.81 (7.08% Increase) Pre-Market Explanation
08:09am, Tuesday, 04'th May 2021
The stock price of ProQR Therapeutics N.V. (NASDAQ: PRQR) increased from $6.36 to $6.81 (up 7.08%) pre-market.
Alphabet, Costco, FedEx, UPS and More Monday Afternoon Analyst Calls
12:25pm, Monday, 03'rd May 2021
With the trading day more than halfway over, the broad markets were somewhat mixed on the day.
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA ther
ProQR Announces Publication in Nature Medicine for Sepofarsen in Leber Congenital Amaurosis 10
04:15pm, Tuesday, 13'th Apr 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 13, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA ther
An End to This Rare Syndrome Could Be an Opportunity for Investors
10:58am, Wednesday, 07'th Apr 2021
A rare genetic disease that causes combined blindness and deafness may have a novel treatment in line after positive phase 1/2 trial results last month.
LEIDEN, Netherlands and CAMBRIDGE, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA t
ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021
04:15pm, Friday, 02'nd Apr 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 02, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA ther
ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares
10:25pm, Tuesday, 30'th Mar 2021
LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA th
ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
04:05pm, Tuesday, 30'th Mar 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA the
PRQR Stock: 7 Things to Know About High-Flying ProQR Therapeutics
02:37pm, Thursday, 25'th Mar 2021
PRQR stock is rocketing up this morning, carrying the momentum of a press release from earlier in the week. Here's what you need to know.
PRQR Stock Price Increased Over 66% Intraday: Why It Happened
01:44pm, Thursday, 25'th Mar 2021
The stock price of ProQR Therapeutics NV (NASDAQ: PRQR) has increased by over 66% intraday. This is why it happened.
